India is the world's third-largest producer of medicines by volume and the largest supplier of generic drugs globally. For franchise buyers, distributors and importers it can be hard to make sense of who does what. This article maps the Indian pharma industry by segment and highlights what to look for in 2026.
1. Listed Innovator & Generic Giants
Companies like Sun Pharma, Dr. Reddy's, Cipla, Lupin, Aurobindo, Torrent and Zydus dominate domestic chronic therapy and global generics. They rarely offer PCD-style franchise models, but they do drive prescription habits and price benchmarks for the rest of the market.
2. Mid-Cap Branded Generics
The next layer — Alkem, Mankind, Glenmark, Ipca, Eris and many regional brands — fills hospital and prescription channels with branded generics. Several offer institutional and trade-only programs that work alongside PCD distribution.
3. PCD & Franchise Specialists
This is where most franchise buyers actually play. Hundreds of mid-sized companies focus exclusively on the PCD model — granting district-wise monopoly to franchise partners. A typical PharmmaEx edition features 200+ such companies, ranging from ₹5 crore to ₹500 crore in turnover. Look for:
- WHO-GMP certified manufacturing
- Genuine monopoly contracts
- Marketing collateral support
- Stable dispatch performance
4. Third-Party / Contract Manufacturers
Hubs in Baddi (Himachal), Sikkim, Selaqui (Uttarakhand), Ahmedabad, Hyderabad and Pune host hundreds of contract manufacturing units producing tablets, capsules, syrups, ointments, sachets and injectables for both domestic brands and exporters.
5. Ayurvedic & Herbal Brands
Patanjali, Himalaya, Dabur and Zandu lead the visible market, but the AYUSH-licensed franchise space is far larger and more fragmented — with hundreds of brands offering classical and proprietary medicines through PCD-style models.
6. Nutraceutical & Wellness Brands
HealthKart, OZiva, MuscleBlaze, Fast&Up and dozens of D2C brands have made nutraceuticals mainstream. Behind them are 100+ contract manufacturers offering private-label collagen, biotin, multivitamins and protein.
7. Veterinary Pharma
Virbac, Zoetis, Vetoquinol and Intas Animal Health lead the listed pack, but the franchise side is dominated by Indian players targeting cattle, poultry, aqua and pet segments.
8. Surgical & Medical Devices
HLL Lifecare, Poly Medicure and HMD lead disposables; Trivitron, Transasia and Mylab dominate diagnostics. Distribution is highly regional and tender-driven.
What This Means for Franchise Buyers
- Decide your segment first — chronic, acute, ayurvedic, derma, nutra, vet — then shortlist companies.
- Pick a WHO-GMP certified partner. No exceptions.
- Compare at least 5 companies in your chosen segment before signing.
- Use pharma expos like PharmmaEx to meet 50+ companies in two days instead of months of online research.
Where to Meet These Companies
PharmmaEx hosts editions in Kolkata, Hyderabad, Ahmedabad, Coimbatore and other cities through 2026. Each edition brings 200–350 verified pharma companies under one roof. Visitor entry is free with pre-registration.
